STILL IN DEVELOPMENT STAGE...IF IT WAS IN PHASE THREE THIS STOCK WOULD BE GIGANTIC! This is a penny stock with Proven Managements and at least 12 Patents..Why are you on this board if you don't like it?
(2ND PART OF ARTICLE ABOVE BUT NOT ALL OF IT).
Together with its licensors and collaborators, OPKO was one of the early pioneers in the field of RNAi,” stated Dr. Geert Cauwenbergh, President and CEO of RXi Pharmaceuticals (RXII
“We are honored to have the privilege to extend OPKO’s ground-breaking work, while at the same time deepening our product pipeline and broadening our technology platform and intellectual property position. Combining OPKO’s RNAi assets and related intellectual property with our self-delivering (sd-rxRNA®) technology platform will further extend our competitive edge in this important field of pharmaceutical development.”
“We are delighted to be joining forces with RXi,” stated Phillip Frost, M.D., OPKO's Chairman and Chief Executive Officer. “RXi has contributed a major advance to the RNAi field with its self-delivering RNAi technology. This technology overcomes a major delivery obstacle of prior RNAi technologies by significantly enhancing the uptake of the gene-targeting drug into cells. We also are impressed with RXi’s development capabilities, as evidenced by its rapid advancement of RXI-109, an exciting product candidate for the potential treatment of dermal scarring.”
About OPKO Health, Inc. (OPK
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies
WESTBOROUGH, Mass. & MIAMI--(BUSINESS WIRE)-- RXi Pharmaceuticals Corporation (RXII
a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, and OPKO Health, Inc. (OPK
today announced a strategic pooling of their respective assets in the field of RNA interference (RNAi). Therapeutics based on RNAi technologies hold great promise to treat a wide range of diseases based on their potential to sustainably down-regulate the expression of a specific gene that may be over-expressed in a disease condition.
According to the terms of an asset purchase agreement jointly executed by the parties, RXi will acquire substantially all of OPKO’s RNAi-related assets, including an extensive intellectual property portfolio. The patent portfolio includes 12 patent families with claims relating to important biological targets, including vascular endothelial growth factor (VEGF), hypoxia-inducible factor 1-alpha (HIF-1-alpha), intracellular adhesion molecule 1 (ICAM-1), angiopoietin 2 (Ang2), and complement component 3 (C3). These molecules are believed to play an important role in diseases of the eye, cancer, immune disorders, and inflammatory diseases. The acquisition is expected to close on March 12, 2013, subject to satisfaction of closing conditions.
As consideration for these assets, RXi will issue to OPKO 50 million shares of its common stock and will make milestone payments to OPKO up to an aggregate of $50 million per product tied to the successful development and commercialization of products utilizing the acquired OPKO intellectual property. In addition, upon commercialization of these products, if approved, RXi would make royalty payments to OPKO.
What about OPTO. do you considere that a scan too...Sure has been one Heck of stock.
SANCHEZDANIEL IS A SHORTY WHO HAS NOTHING BETTER TO DO BUT GET ON BILLBOARDS AND PUMP DOWN A PENNY STOCK. I am long and I admitted it. I am long because of Dr. Frost. What are you doing? You definitely have a hidden adjenda. Why would you be here on this penny stock...unless you are shorting...EXPOSE YOUR SELF Sanchez
Sentiment: Strong Buy
Stock going higher
The key on this stock is DO YOUR RESEARCH ABOUT RXII and OPTO...That is why I am all in. Dr Frost has been a brilliant Investor in Bio Techs. He has been on the board of TEVA in the 70''s. The man has creditials. I AM LONG BABY! and your short scare does not concern me I have done my research and yes, I expect you too do your own research!!
I think you got your conferences mixed up ..I think you went to the ROTH jubilee which is black gay pride. and that Black#$%$ was really another guy not girl! You might want to get check for aids.
Why do I want to get into AONEQ when I am in the best penny sotck ever that actually has substance in RXII?
Please explain. Don't just tell us to get into AONEQ. NOTE: No one pays attention to any one promoting or discounting a stock with out FACTS!
WHY DO YOU CARE IF YOU DON'T LIKE THE STOCK?
Worst come to worst, i don't believe rxii will ever get back down 14.5 cents at opto price deal!
Someone has to ask why someone would spend so much time bashing a stock he does not like. Has this work for you before to get a better entry. If so, I am gain. Today was a good buying opportunity.
The share consolidation proposal is intended to achieve both tactical and strategic objectives. Tactically, the Company's shares must trade above $1 for 10 consecutive days by May 20, 2013 in order to maintain its NASDAQ listing. Maintaining this avenue to trade the Company's shares and enhance liquidity is a key objective of the management team and the Board of Directors. Strategically, a tighter capital float will facilitate future growth initiatives and provide greater visibility in the capital markets, re-positioning the Company's stock price amongst its peers and providing the Company a solid base from which to grow.
As planned, shareholders would receive 1 new consolidated common share for every 2.5 to 3.5 existing common shares; the final ratio will be determined by management closer to the execution of the consolidation. Details regarding the proposal will be outlined in Ivanhoe's management proxy circular to be mailed to shareholders of record on or about March 28, 2013.
Undertaking a share consolidation at this time reinforces the Company's concerted efforts to refocus and restructure itself around its core competencies to create shareholder value
Where do you have your money. Is this why you are on this message board acting like you don't like RXII and bash it because you are looking for dips to buy, or you a really, really boring person who has no hobbies but to bash stocks ;any stocks on all message boards? No, that's it. You have no money and lost it on some other penny stock that you did no research and jelous because you don't have .27 to your name to buy the stock and and live on wellfare?
If NG sells the GAYLORD CREEK project it seems like this stock could be a triple bagger, but gold in general is taking such a beating that it makes you wonder if gold has lost its luster. Do we know if any big insiders have sold NG stock recently?
I think the company needs to just focus more on oil...They doing the same things as DVN. not excuting fast enough to oil. I think we need some changeover of top management. Even though they increase production but income is lower...These managements are Ding, #$%$. Stock has potential, but I don't know about these Dings #$%$s. That is my opinion.
SFY...I am tired of their excuses
If you have a point of view show or point to some facts, otherwise you are wasting your breath, and time on this board. People don't pay attention to people tooting their own horn Promoting or Shorting their own views
There has already been one company that was in PHASE II on RNA prodcut and was bought out. You need to read everything and don't worry about what people tell you. Read facts.
You need to get off this board promoting your trash and spam and probably a virus and your alias.